Literature DB >> 31116081

Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings.

Dejan Jakimovski1, Yi Guan1, Murali Ramanathan2, Bianca Weinstock-Guttman3, Robert Zivadinov1,4.   

Abstract

Multiple sclerosis (MS) is a lifelong inflammatory and neurodegenerative disease influenced by multiple lifestyle-based factors. We provide a narrative review of the effects of modifiable risk factors that are identified as being associated with risk to develop MS and/or influencing the future clinical disease outcomes. The emerging data regarding the beneficial effects of diet modifications and exercise are further reviewed. In contrast, obesity and comorbid cardiovascular diseases are associated with increased MS susceptibility and worse disease progression. In addition, the potential influence of smoking, coffee and alcohol consumption on MS onset and disability development are discussed. Successful management of the modifiable risk factors may lead to better long-term outcomes and improve patients' quality of life. MS specialists should participate in educating and facilitating lifestyle-based modifications as part of their neurological consults.

Entities:  

Keywords:  MRI; alcohol; cardiovascular diseases; diet; exercise; intermittent fasting; multiple sclerosis; obesity; salt; smoking

Year:  2019        PMID: 31116081     DOI: 10.2217/nmt-2018-0046

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  11 in total

Review 1.  SeXX Matters in Multiple Sclerosis.

Authors:  Francesca Gilli; Krista D DiSano; Andrew R Pachner
Journal:  Front Neurol       Date:  2020-07-03       Impact factor: 4.003

Review 2.  Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective.

Authors:  Dejan Jakimovski; Bianca Weinstock-Guttman; Murali Ramanathan; Michael G Dwyer; Robert Zivadinov
Journal:  Vaccines (Basel)       Date:  2020-01-28

3.  Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.

Authors:  Hui Lu; Peng-Fei Wu; Wan Zhang; Xiaoyao Liao
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

4.  A Narrative Review Study on the Effects of Obesity and Bariatric Surgery on Multiple Sclerosis.

Authors:  Zohreh Abna; Seyed Amirhossein Fazeli; Seyedhadi Mirhashemi; Khadijeh Mirzaei; Farbod Emami; Shahin Jamili; Reza Dehghani
Journal:  Ann Indian Acad Neurol       Date:  2021-10-14       Impact factor: 1.383

5.  Growth Factors and Their Roles in Multiple Sclerosis Risk.

Authors:  Hui Lu; Peng-Fei Wu; Deng-Lei Ma; Wan Zhang; Meichen Sun
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

Review 6.  Multiple sclerosis-related fatigue lacks a unified definition: A narrative review.

Authors:  Iman Adibi; Mehdi Sanayei; Farinaz Tabibian; Neda Ramezani; Ahmad Pourmohammadi; Kiarash Azimzadeh
Journal:  J Res Med Sci       Date:  2022-03-17       Impact factor: 1.852

7.  The FTO gene polymorphism rs9939609 is associated with obesity and disability in multiple sclerosis patients.

Authors:  Ahmad Al-Serri; Raed Alroughani; Rabeah A Al-Temaimi
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

8.  Prevalence of seropositivity of selected herpesviruses in patients with multiple sclerosis in the North of Jordan.

Authors:  Raid M Kofahi; Hassan M Kofahi; Suhib Sabaheen; Majdi Al Qawasmeh; Aiman Momani; Ahmed Yassin; Kefah Alhayk; Khalid El-Salem
Journal:  BMC Neurol       Date:  2020-10-29       Impact factor: 2.474

Review 9.  The Nerves to Conduct a Multiple Sclerosis Crime Investigation.

Authors:  Sameeksha Chopra; Zoë Myers; Henna Sekhon; Antoine Dufour
Journal:  Int J Mol Sci       Date:  2021-03-02       Impact factor: 5.923

Review 10.  Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment.

Authors:  Dejan Jakimovski; Samreen Awan; Svetlana P Eckert; Osman Farooq; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2021-12-23       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.